搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Polaromonas sp. Leucine--tRNA ligase (leuS), partial CSB-YP618590PAAI
CSB-EP618590PAAI
CSB-BP618590PAAI
CSB-MP618590PAAI
CSB-EP618590PAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae High-affinity glucose transporter RGT2 (RGT2), partial CSB-YP618591SVG
CSB-EP618591SVG
CSB-BP618591SVG
CSB-MP618591SVG
CSB-EP618591SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Serine/threonine-protein kinase PRR2 (PRR2), partial CSB-YP618592SVG
CSB-EP618592SVG
CSB-BP618592SVG
CSB-MP618592SVG
CSB-EP618592SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YLL059C (YLL059C), partial CSB-YP618593SVG1
CSB-EP618593SVG1
CSB-BP618593SVG1
CSB-MP618593SVG1
CSB-EP618593SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized membrane protein YPR071W (YPR071W), partial CSB-YP618594SVG1
CSB-EP618594SVG1
CSB-BP618594SVG1
CSB-MP618594SVG1
CSB-EP618594SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Non-disjunction protein 1 (NDJ1) CSB-YP618595SVG
CSB-EP618595SVG
CSB-BP618595SVG
CSB-MP618595SVG
CSB-EP618595SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Transposon Ty2-DR1 Gag polyprotein (TY2A-DR1) CSB-YP618596SVG
CSB-EP618596SVG
CSB-BP618596SVG
CSB-MP618596SVG
CSB-EP618596SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polaromonas sp. DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP618597PAAI
CSB-EP618597PAAI
CSB-BP618597PAAI
CSB-MP618597PAAI
CSB-EP618597PAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Sporulation-specific protein 21 (SPO21), partial CSB-YP618598SVG
CSB-EP618598SVG
CSB-BP618598SVG
CSB-MP618598SVG
CSB-EP618598SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YDR010C (YDR010C) CSB-YP618599SVG
CSB-EP618599SVG
CSB-BP618599SVG
CSB-MP618599SVG
CSB-EP618599SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Chromatin modification-related protein EAF3 (EAF3) CSB-YP618600SVG
CSB-EP618600SVG
CSB-BP618600SVG
CSB-MP618600SVG
CSB-EP618600SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Monothiol glutaredoxin-6 (GRX6) CSB-YP618601SVG
CSB-EP618601SVG
CSB-BP618601SVG
CSB-MP618601SVG
CSB-EP618601SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Hsp90 co-chaperone AHA1 (AHA1) CSB-YP618602SVG
CSB-EP618602SVG
CSB-BP618602SVG
CSB-MP618602SVG
CSB-EP618602SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative reductase 1 (YPR1) CSB-YP618603SVG
CSB-EP618603SVG
CSB-BP618603SVG
CSB-MP618603SVG
CSB-EP618603SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Tricalbin-1 (TCB1), partial CSB-YP618604SVG
CSB-EP618604SVG
CSB-BP618604SVG
CSB-MP618604SVG
CSB-EP618604SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Vacuolar-sorting protein SNF8 (SNF8) CSB-YP618605SVG
CSB-EP618605SVG
CSB-BP618605SVG
CSB-MP618605SVG
CSB-EP618605SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized hydrolase YOR131C (YOR131C) CSB-YP618606SVG
CSB-EP618606SVG
CSB-BP618606SVG
CSB-MP618606SVG
CSB-EP618606SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Chromatin assembly factor 1 subunit p90 (RLF2), partial CSB-YP618607SVG
CSB-EP618607SVG
CSB-BP618607SVG
CSB-MP618607SVG
CSB-EP618607SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Serine/threonine-protein kinase SKS1 (SKS1), partial CSB-YP618608SVG
CSB-EP618608SVG
CSB-BP618608SVG
CSB-MP618608SVG
CSB-EP618608SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Actin-like protein ARP6 (ARP6) CSB-YP618609SVG
CSB-EP618609SVG
CSB-BP618609SVG
CSB-MP618609SVG
CSB-EP618609SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>